Cannanine Review – The Label Dose Is a Fraction of the Studied One

The Research Is Genuinely Good

We have reviewed a great many CBD products in this series and spent most of that time explaining why the cited research could not establish causation — unrandomised, unblinded, self-reported, company-funded. The canine literature is a pleasant exception.

The double-blinding matters especially here. Owner-reported improvement in a pet is exactly the outcome you would expect placebo and expectation to inflate — an owner who believes they are helping their dog will see a happier dog. Blinding both the owner and the vet is the correct answer to that, and this study did it.

It is a small trial — 22 dogs — and one study is not a literature. But it is a properly controlled one, and it is the reason canine CBD is taken more seriously than most of the human market.

Now Do the Arithmetic

The most useful thing about that study is that it gives a specific dose, which makes any product checkable. The trial used 2 mg/kg every 12 hours.

The 500mg oil is a 30ml bottle, so roughly 16.7mg per ml. On those figures the label amounts work out at roughly a fifth to a third of the per-dose amount used in the trial — and that is before accounting for frequency, since the study dosed every twelve hours.

This is the same exercise we have run repeatedly across this series — take the studied dose, take the label, divide. It is only possible when a company publishes numbers, and Cannanine does publish a weight-based chart, which is more than most pet CBD brands manage.

Why the Label Dose Is Lower

We think there is a straightforward explanation, and it is not one anybody in this category advertises.

The studied dose is not economically realistic at this price, and that is a fact about the whole pet CBD category rather than a criticism of this brand specifically. Ten cents per milligram is at the top of what we have costed anywhere, and a product priced to be dosed at the researched level would be a very different proposition.

Which produces an uncomfortable but honest conclusion. Either the label dose does something the trial did not test, or the affordable version of this product is a lower-dose version of the thing that was studied. We cannot tell you which, and neither can the packaging — but it is worth going in with the question rather than the assumption.

THC-Free Is the Right Call for Dogs

Credit where it is genuinely due, and this is the most important safety point on the page.

Dogs are considerably more sensitive to THC than humans, for reasons that are anatomical rather than a matter of body size. They have more cannabinoid receptors in the brain, and they experience enterohepatic recirculation — THC excreted by the liver is reabsorbed by the intestines, which prolongs and intensifies the effect rather than clearing it.

Signs of THC toxicosis in dogs include heightened sensitivity to sound, light or touch, lethargy, dilated pupils, slow heart rate, loss of balance, urinary incontinence, vomiting, drooling, tremors or seizures and disorientation. Onset can be 30 minutes to several hours after ingestion and effects can persist up to 72 hours. Prognosis with supportive veterinary treatment is generally good and death is rare — but it is a genuine emergency presentation, and if you suspect it, ring a vet rather than waiting it out.

Veterinary sources note that regulation of CBD manufacturing is limited and trace THC may be present in products generally — which is precisely why a stated THC-free formulation carries more weight for a pet product than it does for a human one. Reviewing a human CBD brand earlier in this series we noted it offered no THC-free option at all; for a dog, that would be a reason to buy elsewhere.

A Naming Inconsistency

A precision point rather than a safety one, but worth noting because the terms have meanings.

The oil is presented as “full spectrum” while the page also states the product contains no THC. Conventionally, “full spectrum” means the complete range of plant compounds including trace THC; a product with the other cannabinoids and terpenes but no THC is usually called broad spectrum. Elsewhere in the range, the hip and joint chews are described as broad spectrum.

The THC-free claim is the one that matters and we take it at face value. But “full spectrum, no THC” is using a term loosely, and in a category where those two words are the main thing distinguishing products, loose usage makes comparison harder than it needs to be.

The Liver Finding Worth Telling Your Vet

One detail from the Cornell study that rarely makes it into marketing, and should.

That is not a reason to avoid CBD, and the study did not report harm. It is a concrete reason to tell your veterinarian your dog is taking it, and to ask whether liver values should be checked — particularly with long-term use, in an older dog, or alongside other medication.

It echoes what we have written about human CBD throughout this series — interactions and liver enzymes are the recurring theme — and a vet who does not know cannot monitor for it. There is no judgement waiting for you in that conversation; supplements are routine and disclosure is simply useful.

The Intervention That Beats Any Supplement

Most people buying this are buying it for a dog with sore joints. So here is the thing worth saying on a weight-management site, plainly.

And the scale of the opportunity is larger than most owners realise. As we found reviewing a pet retailer earlier in this series, survey data puts around 59% of dogs as overweight or obese while only about 17% of owners recognise it. The gap is not carelessness — it is that we calibrate to what we see, and what we see at the park has drifted.

So the first move is a body condition score from a vet, not a supplement. If the answer is that your dog is a healthy weight, CBD becomes a more reasonable thing to discuss. If it is not, the weight is the higher-value intervention and the supplement is treating a symptom of it.

A necessary caution: weight loss in animals needs veterinary supervision, particularly in cats where rapid loss can cause serious liver problems. This is a plan to make with a professional, not a diet to start on your own.

Pros and Cons

Who Should Buy, and How

Talk to your vet first, and specifically ask for a body condition score. If your dog is overweight and has joint pain, that conversation is worth more than this purchase.

If you do buy, buy the THC-free formulation — which here is all of it, and is a genuine reason to prefer a dedicated pet brand over decanting a human product.

Discuss dosing rather than assuming the chart matches the research. The trial used 2mg/kg twice daily; the label appears well below that. Your vet can weigh cost, the liver enzyme finding and your particular dog against each other in a way a bottle cannot.

And tell them you are giving it, so liver values can be monitored if appropriate.

Limitations of This Review

We have not bought, used or tested any Cannanine product, and we are not veterinarians.

The dosing comparison is the most important thing here and carries real caveats. We read two bands from the published chart, not the whole thing, and we could not establish the recommended frequency — if the guidance is twice daily the gap narrows, and if once daily it widens. Our per-ml figure is calculated from stated bottle size and strength rather than read from a label. The Cornell protocol is one trial’s design and not an established minimum effective dose, and we did not read the paper itself, working from published reporting of it.

Other gaps: we could not find a certificate of analysis or establish testing arrangements beyond the company’s own statement, nor the terms of the money-back guarantee. Pricing is as shown and appears promotional. We did not assess the chews, treats, topicals or cat products individually, and the evidence base in cats is considerably thinner than in dogs. We did not read a Trustpilot or BBB record and publish no customer satisfaction score. Nothing here is veterinary advice — dosing, suitability and monitoring are decisions for a veterinarian who has examined your animal.

Frequently Asked Questions

Verdict

The canine CBD literature is better than the human equivalent and it deserves saying. A Cornell randomised, placebo-controlled, owner and veterinarian double-blind crossover trial in 22 dogs with osteoarthritis reported increased comfort and activity — a methodology we have found almost no human CBD product able to match, and one that correctly guards against the obvious problem that an owner who thinks they are helping will see a happier dog.

That study also gives a number, and the number is what makes this reviewable. It used 2mg/kg every twelve hours — around 40mg per dose for a 20kg dog. The published chart here suggests roughly 8mg for a dog in that weight band. Doing the division is not a gotcha; it is the only way to know what you are buying, and it is possible here precisely because Cannanine publishes a chart at all.

The explanation is probably economic rather than evasive. At roughly 10 cents per milligram, dosing at the trial level would run about $240 a month for a mid-sized dog — nobody sells that, and nobody would buy it. But it leaves an honest open question the packaging cannot answer, and the reasonable response is to raise it with a vet rather than assume the bottle matches the study.

What the brand gets clearly right is THC. Dogs have more cannabinoid receptors and recirculate THC through the liver and gut, making them far more sensitive than people, and a stated THC-free product is the correct answer. That alone is a reason to buy a dedicated pet formulation rather than decanting a human one.

And the thing we would most want an owner to take away is not about CBD at all. If your dog has joint pain and is carrying extra weight, weight management is better evidenced than any supplement — and with around 59% of dogs overweight and only 17% of owners aware, the appointment is worth more than the bottle.